Commentar zur Pharmacopoea Germanica
E1479770
UNEXPLORED
Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Commentar zur Pharmacopoea Germanica canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T21350679 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Commentar zur Pharmacopoea Germanica Context triple: [Hermann Hager, notableWork, Commentar zur Pharmacopoea Germanica]
-
A.
Certificates of Suitability to the monographs of the European Pharmacopoeia
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
B.
European Pharmacopoeia
The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
-
C.
Pharmacopeia
Pharmacopeia is a biotechnology company known for pioneering combinatorial chemistry and high-throughput drug discovery technologies.
-
D.
United States Pharmacopeia
The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
-
E.
Japanese Pharmacopoeia
The Japanese Pharmacopoeia is Japan’s official compendium of drug quality standards, specifications, and testing methods that ensures the safety and efficacy of medicines used in the country.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Commentar zur Pharmacopoea Germanica Target entity description: Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
-
A.
Certificates of Suitability to the monographs of the European Pharmacopoeia
Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
-
B.
European Pharmacopoeia
The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
-
C.
Pharmacopeia
Pharmacopeia is a biotechnology company known for pioneering combinatorial chemistry and high-throughput drug discovery technologies.
-
D.
United States Pharmacopeia
The United States Pharmacopeia is an official compendium that sets quality, purity, strength, and identity standards for medicines, food ingredients, and dietary supplements used in the United States and many other countries.
-
E.
Japanese Pharmacopoeia
The Japanese Pharmacopoeia is Japan’s official compendium of drug quality standards, specifications, and testing methods that ensures the safety and efficacy of medicines used in the country.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.